Boston, MA, United States of America

Charles Y Lin

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Whitehead Institute for Biomedical Research. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Charles Y Lin

Introduction

Charles Y Lin is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of biomedical research, particularly in the area of gene expression modulation. His work is essential for understanding cell identity and disease states.

Latest Patents

Charles Y Lin holds a patent for "Super-enhancers and methods of use thereof." This invention relates to super-enhancers and associated compositions, methods, and agents that are useful for modulating the expression of cell type-specific genes. These genes are crucial for maintaining cell identity, such as embryonic stem cell identity, or for sustaining disease states like cancer. He has 1 patent to his name.

Career Highlights

Lin is affiliated with the Whitehead Institute for Biomedical Research, where he conducts groundbreaking research. His work has implications for both basic science and therapeutic applications, making him a key figure in his field.

Collaborations

Throughout his career, Charles has collaborated with notable researchers, including Jakob Loven and Denes Hnisz. These partnerships have enhanced the impact of his research and contributed to advancements in understanding gene regulation.

Conclusion

Charles Y Lin's innovative work in gene expression modulation highlights his importance in the biomedical research community. His contributions continue to pave the way for future discoveries in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…